Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082348 | SCV000114311 | benign | not specified | 2012-12-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082348 | SCV000169704 | benign | not specified | 2012-02-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000082348 | SCV000195369 | benign | not specified | 2013-12-17 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000443306 | SCV000511811 | benign | not provided | 2016-07-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000470827 | SCV000559146 | benign | Angelman syndrome | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000082348 | SCV000616227 | benign | not specified | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313829 | SCV000847740 | benign | Inborn genetic diseases | 2016-06-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000443306 | SCV002563227 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | UBE3A: BS2 |
Prevention |
RCV003915104 | SCV004734373 | likely benign | UBE3A-related condition | 2019-06-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000470827 | SCV000733428 | benign | Angelman syndrome | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000443306 | SCV001932085 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000082348 | SCV001958722 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000082348 | SCV001969995 | benign | not specified | no assertion criteria provided | clinical testing |